Related Experiment Video
Updated: Jul 9, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Infantile onset panniculitis with uveitis and systemic granulomatosis: a new clinicopathologic entity
Carine H Wouters1, Tammy M Martin, Dorothee Stichweh
1University Hospital Gasthuisberg, Leuven, Belgium. carine.wouters@uz.kuleuven.ac.be
Insights
Four children experienced infantile-onset lobular panniculitis with fever and uveitis. Standard immunosuppressive therapy was ineffective, but anti-tumor necrosis factor monoclonal antibody showed promise in treating this rare inflammatory condition.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Genetics
Background:
- Infantile-onset lobular panniculitis is a rare inflammatory condition.
- Associated symptoms include high fever, uveitis, and systemic granulomatous inflammation.
- Genetic mutations in CARD15 and CIAS1 are not consistently found in these cases.
Purpose of the Study:
- To describe the clinical characteristics and treatment outcomes of children with infantile-onset lobular panniculitis.
- To investigate the genetic basis of this condition.
- To evaluate the efficacy of different therapeutic strategies.
Main Methods:
- Case series of 4 children recruited through the International Registry of Pediatric Granulomatous Arthritis.
- Clinical data collection including symptoms, disease course, and treatment response.
- Genetic analysis for CARD15 and CIAS1 mutations.
Main Results:
- All 4 patients presented with infantile-onset lobular panniculitis, high fever, uveitis, and systemic granulomatous inflammation.
- No mutations in CARD15 or CIAS1 were identified.
- Disease progression was observed despite conventional immunosuppressive therapy.
- Three out of four patients showed a positive response to anti-tumor necrosis factor monoclonal antibody treatment.
Conclusions:
- Infantile-onset lobular panniculitis is a severe condition unresponsive to standard immunosuppression.
- Genetic testing for CARD15 and CIAS1 may not be informative in all cases.
- Anti-tumor necrosis factor monoclonal antibody therapy represents a potential treatment option for this challenging pediatric inflammatory disease.
Abstract:
We report on 4 children with infantile-onset lobular panniculitis, high fever, uveitis, and systemic granulomatous inflammation, recruited through the International Registry of Pediatric Granulomatous Arthritis. Neither CARD15 nor CIAS1 mutations were found. Despite immunosuppressive therapy, disease course was progressive. Response to anti-tumor necrosis factor monoclonal antibody in 3 patients is of note.
Related Concept Videos
Chronic Pancreatitis II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Chronic Inflammation: Introduction
Encephalitis ll: Pathophysiology
Endocarditis II: Clinical Features of Infective Endocarditis
Nephrotic Syndrome I : Introduction
